<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/64300AF7-F2A5-4EEC-983A-CC4168C9C664"><gtr:id>64300AF7-F2A5-4EEC-983A-CC4168C9C664</gtr:id><gtr:name>Virginia Commonwealth University</gtr:name><gtr:address><gtr:line1>Virginia Commonwealth University</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Life Sciences</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/64300AF7-F2A5-4EEC-983A-CC4168C9C664"><gtr:id>64300AF7-F2A5-4EEC-983A-CC4168C9C664</gtr:id><gtr:name>Virginia Commonwealth University</gtr:name><gtr:address><gtr:line1>Virginia Commonwealth University</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CB05C424-91BF-4B48-9472-E6F6226A6A05"><gtr:id>CB05C424-91BF-4B48-9472-E6F6226A6A05</gtr:id><gtr:name>University of London</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Malet Street</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 7HU</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E3421A0E-56E3-4FA1-9A86-A911434E17EC"><gtr:id>E3421A0E-56E3-4FA1-9A86-A911434E17EC</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>Alan</gtr:otherNames><gtr:surname>Hare</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1100332"><gtr:id>0441173B-9F65-4A60-AE78-E3A75AE0A737</gtr:id><gtr:title>Structural and Functional Investigation of Meningococcal TonB Dependent Transporters</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G1100332</gtr:grantReference><gtr:abstractText>Neisseria meningitidis (the meningococcus) is a major worldwide health concern causing septicaemia and bacterial meningitis. Meningococcal septicaemia develops rapidly and is fatal in 10% of cases and survivors can face permanent disability. There is currently no approved vaccine that protects against all meningococcal strains.

As a defence mechanism against invading bacteria, the human iron transport proteins transferrin and lactoferrin restrict iron availability. The meningococcus, with a requirement for iron, has two specialised iron transporter proteins on its surface that bind transferrin and lactoferrin and strip iron from them by an unknown mechanism. This project aims to investigate the structures of these transporters bound to their target human proteins, thus revealing the mechanism by which they collect iron. 
This project will also investigate a) the structure of a related iron transporter that is currently in clinical trials as a vaccine component and b) the function and target uptake molecule of a similar transporter protein shown to be important in the initial meningococcal colonisation of the nasal pharynx. Results from these studies will improve our understanding of meningococcal infection, help in the development of meningococcal vaccines and potentially lead to novel antibiotic targets.</gtr:abstractText><gtr:technicalSummary>Neisseria meningitidis (the meningococcus) is a human host specific pathogen and a major cause of bacterial meningitis and sepsis. Meningococcal septicaemia develops rapidly and is fatal in about 10% of cases with survivors facing the possibility of permanent disability. There is currently no approved vaccine that protects against all circulating meningococcal strains.
An essential feature of meningococcal survival and replication is its ability to extract iron from the human iron transport proteins transferrin and lactoferrin. The mechanism of this iron extraction is unknown but the key players are the outer membrane TonB dependent transporters (TBDTs) TbpA and LbpA (Transferrin/Lactoferrin binding protein A). Other interesting meningococcal TBDTs studied herein include the siderophore receptor FetA, a potential vaccine candidate, and NMB1829, which has an unidentified transport substrate but aids host colonisation. 
This project will investigate the structural basis of iron uptake from host proteins by TbpA and LbpA. Initial investigations will study the formation of complexes between the TBDT, its target host protein and secondary lipoprotein with the aim of establishing a stable, monodispersed complex suitable for structural studies. The ultimate aim of this part of the work is to elucidate a high-resolution structure of binary or tertiary complexes to explain the iron uptake mechanism.
This project also aims to solve the structure of FetA to aid its development as a vaccine component. A collaborating meningococcal vaccine consortium has incorporated FetA into a vaccine formulation due to enter Phase I clinical trials and are therefore interested in its structure.
An additional TonB dependent receptor (NMB1829) has been identified as important for meningococcal colonisation of the nasal pharynx and will also be targeted with the aim of not only solving its structure, but more importantly revealing its target molecule by analysing protein expression and bacterial survival in the presence or absence of potential nutrients.
The same screen that identified NMB1829?s role in colonisation also identified three soluble proteins as being important colonisation factors. This project will also structurally characterise these virulence factors and use the resulting structures and specific mutations to test predictions of their functions using biochemistry and microbiology experiments. Deciphering the roles of these proteins and other uncharacterised virulence factors is an important goal as it could lead to the identification of new virulence pathways and antibiotic targets in the meningococcus and potentially in other bacterial pathogens.</gtr:technicalSummary><gtr:fund><gtr:end>2016-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>646422</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Virginia Commonwealth University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Mutational analysis of HpuA</gtr:description><gtr:id>FCE6DC1F-CFF0-4CDB-A929-BF0F56F07C1D</gtr:id><gtr:impact>This collaboration is leading ot a greater understanding of heme uptake by pathogenic neisseria. It is multi-disciplinary involving structural biology, biophysics and microbiology</gtr:impact><gtr:outcomeId>545b7fb5831ff0.52786605-1</gtr:outcomeId><gtr:partnerContribution>Our partners are conducting mutagenesis in live gonococci and analysing the effect on hemoglobin binding and heme uptake.</gtr:partnerContribution><gtr:piContribution>We solved the HpuA:haemoglobin complex structure and analysed interaction biochemically.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visits to CMBI open day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>AF7C7021-42D4-4BC7-B95C-86D0034E01D1</gtr:id><gtr:impact>Approximately 100 pupils attended the open day. As part of this we discussed with them how using x-rays can help us 'see' things not visible under light microscopes and gave them hands on experience with microscopes and setting up crystallisation experiments.

Pupils were excited by the science on display and being able to get their hands on some equipment.</gtr:impact><gtr:outcomeId>DPcWeWihxff</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>51584</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Medical Research Foundation</gtr:department><gtr:description>EQUIPMENT COMPETITION FOR MRC-FUNDED MID-CAREER RESEARCHERS IN UK UNIVERSITIES</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>C0493</gtr:fundingRef><gtr:id>8C96A108-0B0D-4889-84CA-5453F11E4A73</gtr:id><gtr:outcomeId>545b7de6a621e4.96845893</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>FB8D1940-478F-454A-957E-AAE703BD204E</gtr:id><gtr:title>Structural analysis of haemoglobin binding by HpuA from the Neisseriaceae family.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/272f855bf6aa8fb463010142ddda681e"><gtr:id>272f855bf6aa8fb463010142ddda681e</gtr:id><gtr:otherNames>Wong CT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56d6e61836fc31.91033451</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0445835C-AA4F-4AFC-BBDA-5771271D4B8B</gtr:id><gtr:title>A Salmonella Toxin Promotes Persister Formation through Acetylation of tRNA.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8de142475185651a1ad88364e8e709eb"><gtr:id>8de142475185651a1ad88364e8e709eb</gtr:id><gtr:otherNames>Cheverton AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>585d6a63bd3d57.75848960</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23274435-4444-4082-B2F9-C397E8158A88</gtr:id><gtr:title>The Salmonella Effector SpvD Is a Cysteine Hydrolase with a Serovar-specific Polymorphism Influencing Catalytic Activity, Suppression of Immune Responses, and Bacterial Virulence.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1055e5acc1a80b93bac3fe32004b3518"><gtr:id>1055e5acc1a80b93bac3fe32004b3518</gtr:id><gtr:otherNames>Grabe GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5a2fd368308be7.03928157</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>831E53A3-C1D4-4982-8610-9A0660ECE078</gtr:id><gtr:title>Purification, crystallization and characterization of the Pseudomonas outer membrane protein FapF, a functional amyloid transporter.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c97934711d930e1e6bf4d489af5dd6cc"><gtr:id>c97934711d930e1e6bf4d489af5dd6cc</gtr:id><gtr:otherNames>Rouse SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2053-230X</gtr:issn><gtr:outcomeId>588b5b8085d9b3.29710933</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1100332</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>D8F3A27D-084A-40BB-A046-087DACE23410</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>3.4  Vaccines</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>